Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
WayPath Pharma
AddedFeb 18, 2024
UpdatedJun 18, 2026
WayPath Pharma

WayPath Pharma

Angel

WayPath Pharma: A companion animal pharmaceutical firm specializing in cancer research.

HQ
Metairie, LA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to advance veterinary medicine, WayPath Pharma is a companion animal pharmaceutical company specializing in cancer research. The company aims to develop groundbreaking anti-cancer treatments specifically for canines, addressing a critical need in the veterinary market. By focusing on innovative chemistry and targeted therapies, WayPath Pharma seeks to improve the quality of life for pets battling cancer.

Notable figures associated with WayPath Pharma include leading veterinary oncologists and experienced pharmaceutical researchers. The company has attracted significant interest from investors focused on biotech and animal health sectors. Key achievements include the development of a pioneering anti-cancer regimen for dogs, which has shown promising results in early trials. WayPath Pharma's impact is reflected in its commitment to enhancing pet health and extending the lives of companion animals through advanced medical solutions.

WayPath Pharma - Similar Companies

Hylapharm logo

Hylapharm

hylapharm.com

Onchilles Pharma logo

Onchilles Pharma

Camino Pharma logo

Camino Pharma

caminopharma.com

Elias Animal Health logo

Elias Animal Health

PleoPharma logo

PleoPharma

pleopharma.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Ernest Pharmaceuticals logo

Ernest Pharmaceuticals

ernestpharma.com

Taxis Pharmaceuticals logo

Taxis Pharmaceuticals

taxispharma.com

Pathalys Pharma logo

Pathalys Pharma

pathalys.com

Underdog Pharmaceuticals logo

Underdog Pharmaceuticals

cyclaritytx.com

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Marius Pharmaceuticals logo

Marius Pharmaceuticals

mariuspharma.com

Path BioAnalytics logo

Path BioAnalytics

Cage Pharma logo

Cage Pharma

cagephar.ma

Petros Pharmaceuticals logo

Petros Pharmaceuticals

petrospharma.com

WayPath Pharma - Quick Facts

Who are WayPath Pharma's competitors?

Companies similar to WayPath Pharma include Hylapharm, Onchilles Pharma, Camino Pharma and Elias Animal Health.

When was WayPath Pharma founded?

WayPath Pharma was founded in 2019.

Where is WayPath Pharma's headquarters located?

WayPath Pharma's headquarters is located in Metairie, LA, US.

When was WayPath Pharma's last funding round?

WayPath Pharma's most recent funding round was for $225k (USD) in October 2022.

How much has WayPath Pharma raised to-date?

As of Oct 11, 2022, WayPath Pharma has raised a total of $225k (USD).

How many employees does WayPath Pharma have?

WayPath Pharma has 1 employee as of Feb 4, 2024.

WayPath Pharma - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified